Official UK visa sponsor profile for Curaleaf International Limited in LONDON, including current register status, route details, and public company data.
Curaleaf International Limited is a research and experimental development company specializing in the exploration of cannabis’s therapeutic potential for medicinal applications. Established in 2018 and currently active, Curaleaf operates under the SIC codes – 72190 – and is registered with the Regulatory Information Service (RIS) in the UK. The company’s primary focus is dedicated to investigating and analyzing the potential benefits of cannabis within the medical field. Curaleaf’s activities encompass a range of research projects, aiming to identify specific therapeutic uses for cannabis. This includes preclinical studies, formulation development, and analysis of potential drug interactions and efficacy. The company’s international presence is a key element of its strategy, reflecting a global perspective on cannabis research. As a limited company, Curaleaf employs a team of skilled workers, currently rated as a Worker (A rating). The company’s operations are driven by a commitment to scientific rigor and innovation, exploring novel applications of cannabis within the medical landscape. The company’s strategic focus is on deepening the understanding of cannabis’s therapeutic capabilities.
Official UK visa sponsor profile for Curaleaf International Limited in LONDON, including current register status, route details, and public company data.
Curaleaf International Limited is a research and experimental development company specializing in the exploration of cannabis’s therapeutic potential for medicinal applications. Established in 2018 and currently active, Curaleaf operates under the SIC codes – 72190 – and is registered with the Regulatory Information Service (RIS) in the UK. The company’s primary focus is dedicated to investigating and analyzing the potential benefits of cannabis within the medical field. Curaleaf’s activities encompass a range of research projects, aiming to identify specific therapeutic uses for cannabis. This includes preclinical studies, formulation development, and analysis of potential drug interactions and efficacy. The company’s international presence is a key element of its strategy, reflecting a global perspective on cannabis research. As a limited company, Curaleaf employs a team of skilled workers, currently rated as a Worker (A rating). The company’s operations are driven by a commitment to scientific rigor and innovation, exploring novel applications of cannabis within the medical landscape. The company’s strategic focus is on deepening the understanding of cannabis’s therapeutic capabilities.
Yes, Curaleaf International Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Curaleaf International Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Curaleaf International Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Curaleaf International Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.